KIR3DL1 and non-small cell lung carcinoma: Interestingly, patients with bile duct cancer show multiple alterations at KIR gene loci (46), and genetic variations in KIRs are also present in non-small cell lung cancer patients who are resistant to anti-PD-1 monotherapy (47).